PubRank

Danstan Bagenda

Author PubWeight™ 35.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 2003 11.30
2 Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics. J Acquir Immune Defic Syndr 2005 2.63
3 Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study. BMC Pediatr 2010 1.51
4 Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, Uganda. J Acquir Immune Defic Syndr 2010 1.50
5 Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda. J Acquir Immune Defic Syndr 2007 1.20
6 Noninferiority of a task-shifting HIV care and treatment model using peer counselors and nurses among Ugandan women initiated on ART: evidence from a randomized trial. J Acquir Immune Defic Syndr 2013 1.16
7 The good, the bad, and the unknown: quality of clinical laboratories in Kampala, Uganda. PLoS One 2013 1.14
8 Response to antiretroviral therapy in HIV-infected Ugandan children exposed and not exposed to single-dose nevirapine at birth. J Acquir Immune Defic Syndr 2009 1.12
9 Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children. Pediatr Infect Dis J 2012 0.99
10 In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine. AIDS Res Hum Retroviruses 2009 0.98
11 Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda. AIDS 2002 0.98
12 Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants. J Acquir Immune Defic Syndr 2010 0.98
13 Effect of chloroquine on human immunodeficiency virus (HIV) vertical transmission. Afr Health Sci 2003 0.95
14 Multivitamin supplementation in HIV infected adults initiating antiretroviral therapy in Uganda: the protocol for a randomized double blinded placebo controlled efficacy trial. BMC Infect Dis 2012 0.90
15 Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection. Antivir Ther 2012 0.88
16 Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. AIDS Res Hum Retroviruses 2010 0.87
17 Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission. J Infect Dis 2008 0.87
18 Modelling the potential impact and cost of scaling-up male circumcision in resource poor settings: A case of Uganda. Afr J AIDS Res 2013 0.86
19 Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration. AIDS 2010 0.84
20 Distribution of haematological and chemical pathology values among infants in Malawi and Uganda. Paediatr Int Child Health 2012 0.81
21 Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation. Diagn Cytopathol 2010 0.80
22 Long-term clinical and immunologic outcomes of HIV-infected women with and without previous exposure to nevirapine. Trop Med Int Health 2013 0.78
23 Analysis of HIV tropism in Ugandan infants. Curr HIV Res 2010 0.78
24 University students and the risk of HIV and other sexually transmitted infections in Uganda: the Crane survey. Int J Adolesc Med Health 2014 0.78
25 Depressive and Anxiety Symptoms Predict Sustained Quality of Life Deficits in HIV-Positive Ugandan Adults Despite Antiretroviral Therapy: A Prospective Cohort Study. Medicine (Baltimore) 2016 0.77
26 A look at ethics and AIDS -- We're trying to help our sickest people, not exploit them In the researcher's code of conduct, contradictions abound. Washington Post 1997 0.75